A. Muldal
Queen's University · 15 works · 998 citations · h-index 10
Top works
- Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement
- Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)
- Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.
- Parental care of nestlings by male red-winged blackbirds
- Gemcitabine in advanced renal cell carcinoma
- Preferred Nest Spacing of an Obligate Cavity-Nesting Bird, the Tree Swallow
- Docetaxel in advanced renal carcinoma
- Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
- Didemnin B in favourable histology non-Hodgkin's lymphoma
- Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma
- P28 Response criteria in solid tumours: UNI-dimensional vs BI-dimensional measurements
- 30P Classification and reduction of queries on multi-centre trials
- Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon α-2a in previously treated patients with multiple myeloma
- P28 Response criteria in solid tumours: UNI-dimensional vs BI-dimensional measurements
- P04 Establishment of an adverse event reporting (AER) database: The National Cancer Institute of Canada clinical trials group (NCIC CTG) experience